GlassScriptPhysician profile
Tyler Gordon Marks
NPI 1659533412
$1,766.49
in general payments reported to CMS, 2019-2025
15 companies · $96.85 in 2025
The $96.85 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,159 · 2020: $125 · 2021: $149 · 2022: $137 · 2023: $17.25 · 2024: $82.08 · 2025: $96.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $1,049.76 | 2019-2020 | |
| Depuy Synthes Sales INC. | $160.77 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $131.86 | 2020-2022 | |
| Smith+Nephew, INC. | $76.51 | 2019 | |
| Boston Scientific Corporation | $62.32 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Innovation Technologies INC | $55.77 | 2025 | Irrisept |
| Endo USA, INC. | $35.28 | 2024-2025 | Xiaflex |
| Baxter Healthcare | $33.27 | 2022 | |
| Stryker Corporation | $32.83 | 2022 | |
| Avanos Medical | $29.76 | 2019 | |
| Bioventus LLC | $23.44 | 2025 | Xcell |
| Pacira Pharmaceuticals Incorporated | $22.65 | 2024 | Exparel |
| Abbvie INC. | $19.89 | 2024 | |
| Vericel Corporation | $16.47 | 2019 | |
| Horizon Therapeutics Plc | $15.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.